The rule makes explicit that LDTs are in vitro diagnostics and as such are subject to oversight by FDA under the Federal Food ...

As demonstrated during the COVID-19 pandemic and in newer research, saliva holds promise as an alternative sample type for ...

DeepUll showcased its UllCore platform and UllCore BSI Test, a one-hour multiplex PCR assay targeting 95 percent of ...

Infectious disease firm Karius announced on Thursday that it has raised $100 million in a Series C financing round with new and existing investors. The funding round ...

The new test joins Abbott's existing portfolio of laboratory-based tests that utilize the same neurology biomarkers.

The cases could overturn a legal principle known as the "Chevron doctrine" under which courts have typically deferred to ...

The company's CEO stepped down in March as the firm began a business review to determine its strategic direction.

Of the 30 companies in the index, six companies saw their share price rise last month, while 24 companies saw their stock prices decline.

Due to incorrect ceftriaxone concentrations in the antimicrobial susceptibility testing cards, use of an alternative method is advised for certain results.

The company's Diagnostics and Genomics segment saw revenue growth of 16 percent, while the Protein Sciences segment's revenues declined 2 percent.

While the parasitic infection is primarily spread through insect vectors, it can also be transmitted congenitally and is often asymptomatic in newborns.

In a BioMérieux-sponsored symposium, economist Lord Jim O'Neill revisited a 2016 report on AMR while experts discussed the use of rapid testing tools such as those offered by the French company.